苗医药发展现状、机遇及面临的挑战发微
A Brief Discussion on the Development Status, Opportunities and Challenges of Miao Medicine
DOI: 10.12677/acm.2024.1451678, PDF,    科研立项经费支持
作者: 段学清, 朱 晨, 田维毅*:贵州中医药大学基础医学院,贵州 贵阳
关键词: 苗医药发展现状机遇挑战微论Miao Medicine Development Status Opportunity Challenge A Brief Discussion
摘要: 苗医药是一种源自中国苗族的传统医学体系,具有悠久的历史和丰富的实践经验。在我国,苗医药得到了广泛的认可和应用。近几年来,科技的飞速发展促使苗医药的研究取得了丰富的成果。这些成果不仅在治疗常见疾病和多发病方面表现出色,也对预防和治疗重大疾病以及保健养生等领域起到了关键作用。同时,苗医药在国际交流与合作中逐渐受到关注,成为我国传统医学的重要组成部分。然而,现代医学的快速发展也使得苗医药在某些方面面临挑战。如何在传承经典的基础上进行创新,以适应现代医学的发展和患者需求。在此,本文对苗医药发展现状、机遇及面临的挑战发表微论,以期为苗医药事业的繁荣和发展提供参考。
Abstract: Miao medicine is a traditional medical system originating from the Miao ethnic group in China, with a long history and rich practical experience. In our country, Miao medicine has been widely recognized and applied. Over the past few years, advancements in science and technology have led to successful research on Miao medicine. This traditional practice has shown promising outcomes in the treatment of common ailments and has proven to be beneficial in the management and prevention of serious health conditions. Miao medicine has gained recognition in international exchanges and collaboration, becoming a significant component of traditional Chinese medicine. Nevertheless, the swift advancement of modern medicine has posed difficulties to Miao medicine in certain areas: How to innovate on the basis of inheriting classics to adapt to the development of modern medicine and meet patient needs. In this regard, this article discusses the current status, opportunities, and challenges of Miao medicine, in the hope of providing a reference for the prosperity and development of the Miao medicine cause.
文章引用:段学清, 朱晨, 田维毅. 苗医药发展现状、机遇及面临的挑战发微[J]. 临床医学进展, 2024, 14(5): 2253-2257. https://doi.org/10.12677/acm.2024.1451678

参考文献

[1] 廖晓语, 潘婷. 苗医药文化生态研究[J]. 品牌研究, 2020(9): 88-89.
[2] 苗族医学史编写组. 苗族医学史[M]. 贵阳: 贵州人民出版社, 1990.
[3] 李明华, 张晓峰. 苗医药发展概述[J]. 中华中医药学刊, 2012, 27(6): 1301-1304.
[4] 王晓梅, 杨晓晖. 苗医药理论体系的研究[J]. 河南中医学院学报, 2015, 30(7): 1017-1020.
[5] 张伯驹. 苗医概论[M]. 贵阳: 贵州人民出版社, 1984.
[6] 赵立燕, 刘永胜, 张建春. 苗医药药物资源的研究现状与展望[J]. 中国中医药信息杂志, 2017, 24(4): 54-57.
[7] 刘海燕, 刘宏伟, 陈雪梅. 苗医药疗法特点及应用研究[J]. 山东中医药大学学报, 2011, 35(2): 137-140.
[8] 王承德, 黄贵峰. 苗医药现代化研究[J]. 中华中医药学刊, 2010, 25(6): 1223-1226.
[9] 李洪涛, 张雪峰, 赵春雨. 苗医药发展现状及对策研究[J]. 中华中医药学刊, 2018, 33(22): 463-466.
[10] 杨秀梅, 张晓峰. 苗药有效成分的研究进展[J]. 天然产物研究与开发, 2015, 27(10): 1647-1654.
[11] 盛思晗, 沈征武. 青蒿素类化合物抗肿瘤作用机制研究进展[J]. 中南药学, 2024, 22(2): 453-458.
[12] Uckun, F.M., Saund, S., Windlass, H. and Trieu, V. (2021) Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug. Frontiers in Pharmacology, 12, Article 649532. [Google Scholar] [CrossRef] [PubMed]
[13] Hao, D.C., Hou, X.D., et al. (2021) Ethnopharmacology, Chemodiversity, and Bioactivity of Cephalotaxus Medicinal Plants. Chinese Journal of Natural Medicines, 19, 321-338. [Google Scholar] [CrossRef
[14] Weaver, B.A. (2014) How Taxol/Paclitaxel Kills Cancer Cells. Molecular Biology of the Cell, 25, 2677-2681. [Google Scholar] [CrossRef] [PubMed]
[15] Peng, X., Huang, C., Zhang, N., et al. (2022) The Mechanism Study of Miao Medicine Tongfengting Decoction in the Treatment of Gout Based on Network Pharmacology and Molecular Docking. Medicine, 101, e32300. [Google Scholar] [CrossRef
[16] 杨孝余, 罗丰, 袁雪梅, 等. 苗医药治疗风湿类疾病研究进展[J]. 亚太传统医药, 2023, 19(11): 244-248.
[17] 梁江, 马武开, 刘正奇, 等. 黑骨藤乙醇提取物影响人类风湿关节炎滑膜成纤维细胞增殖及COX-2、PEG-2表达的研究[J]. 时珍国医国药, 2015, 26(1): 24-27.
[18] Zhu, L.R., Li, S.S., Zheng, W.Q., et al. (2023) Targeted Modulation of Gut Microbiota by Traditional Chinese Medicine and Natural Products for Liver Disease Therapy. Frontiers in Immunology, 14, Article 1086078. [Google Scholar] [CrossRef] [PubMed]
[19] 饶凯瑞, 廖彩岑, 伊然, 等. 雷公藤二萜类化合物通过抑制多条信号通路缓解巨噬细胞炎症反应[J]. 中国药理学通报, 2023, 39(1): 153-160.
[20] 杨钧屹. 基于文献计量法分析近10年我国苗药的研究进展[J]. 贵州农业科学, 2019, 47(8): 129-132.
[21] 刘晓梦, 胡志平. 苗药现代研究进展[J]. 黔南民族医专学报, 2017, 30(2): 152-153.
[22] 杨永刚, 吴建生, 张雨桐. 苗医药研究现状与发展趋势[J]. 中华中医药杂志, 2021, 23(2): 1020-1025.
[23] 国务院. 中医药发展战略规划纲要(2016-2030年) [R]. 北京: 中国政府网, 2016.
[24] 刘维忠. 加强民族医药工作的探讨与实践[J]. 中华中医药学刊, 2017, 32(6): 1611-1614.
[25] 杨秀娟, 王蕾. 民族医药发展现状及对策研究——以苗医药为例[J]. 现代商贸工业, 2019, 40(10): 135-136.
[26] 曹宇雯. 试论我国生物医药产业发展现状及对策[J]. 经济师, 2017(6): 82-83.